TTKHLTCAREDiversified

TTK Healthcare Limited

Diversified · ISIN INE910C01018 · BSE 507747 · NSE EQ · FV ₹10
Last price
₹1,049
-1.51%today
What this company does

TTK Healthcare Limited operates in the Diversified sector. It booked ₹258 cr of revenue in its latest quarter (Q1 FY27) and kept 8.3% of sales as profit. It is the 5th largest of 5 Diversified companies we track, by market value.

In the report:
56out of 100
Equitytale Health Score
Mixed

Healthier than 56% of listed companies we score, on all six measures of filed financials. Each measure is ranked against the 1,201–2,858 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
42

At close. Not part of the score.

Profitability & returns41

How much profit it earns on the money it employs

Balance sheet87

How much it owes, and whether earnings cover the interest

Cash quality22

Whether reported profit actually arrives as cash

Growth & consistency38

Whether sales and profit have grown, and how steadily

Valuation63

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 14% vs last year
Profit up 64% vs last year
Promoters hold 75%
No promoter shares pledged
Virtually debt-free
Watch-outs
! Low 7.6% return on equity
! Operating cash flow is negative

What if I invest in TTKHLTCARE?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹1,049 -1.51%
latest close · 2026-09-17
1-year return
+52.3%
52-wk low ₹62252-wk high ₹1,247
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio17.4Average
LowAverageHigh
P/B ratio1.33Moderate
Below bookModerateHigh
EV / EBITDA11.8Average
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity7.6%Weak
WeakFairStrong ▸15%
Return on capital10.5%Fair
WeakFairStrong
Net margin8.3%Decent
ThinDecentStrong
EBITDA margin12.2%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.02Comfortable
LowModerateHigh ▸1
Interest cover55.3×Strong
RiskyOkayStrong ▸5×
Current ratio5.91Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹1,482 cr
Book value
₹789
EPS
₹15.06
latest quarter
Net debt
₹2 cr
owes more than its cash
Enterprise value
₹1,484 cr
EBITDA
₹126 cr
annualised
EBIT
₹118 cr
annualised
Operating margin
11.4%
Return on assets
6.4%
Earnings yield
5.74%
P/S
1.44
Sales / share
₹729.1
Tax rate
26.3%
Face value
₹10
Shares
1.4 cr
Working capital
₹1,012 cr
Current assets
₹1,218 cr
Current liabilities
₹206 cr
Delivery %
54.7%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Hard to value confidentlyLow confidence
One year's profit is a one-off (far above the multi-year norm), so its recurring earnings power is unclear.
Models span ₹318₹959, midpoint ₹889

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹258 cr
Other Income₹17 cr
Total Income₹274 cr
Cost of Materials₹61 cr
Purchases of Stock-in-Trade₹55 cr
Inventory Change (±)₹-2 cr
Employee Benefit Expense₹47 cr
Finance Costs₹53.1 L
Depreciation & Amortisation₹2 cr
Other Expenses₹82 cr
Total Expenses₹245 cr
Profit before Tax₹29 cr
Tax Expense₹8 cr
Net Profit₹21 cr
Net margin on total income7.8%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹114 cr41.6%
Employee benefit expense₹47 cr17.0%
Finance costs₹53.1 L0.2%
Depreciation & amortisation₹2 cr0.8%
Other expenses₹82 cr29.9%
Tax expense₹8 cr2.8%
Profit for the period₹21 cr7.8%
Total income ₹274 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue209 cr218 cr258 cr
Total income227 cr236 cr274 cr
Expenses205 cr210 cr245 cr
Profit before tax14 cr30 cr29 cr
Tax4 cr8 cr8 cr
Net profit (owners' share)11 cr22 cr21 cr
Net margin (owners' share, on revenue)5.0%10.0%8.3%
EPS (₹)7.4515.4015.06
YoY (latest quarter): total income +12.3% · net profit +63.7%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹1,329 cr
Shareholder equity
₹1,115 cr
parent shareholders
Total debt
₹24 cr
Cash
₹22 cr
Cash flow · H1 FY26
Operating
₹-23 cr
Investing
₹40 cr
Financing
₹-14 cr
Peer comparison
Diversified · by market value
CompanyPriceMarket capP/E
Godrej Industries Limited₹1,127₹37,967 cr33.4
3M India Limited₹32,530₹36,645 cr58.3
DCM Shriram Limited₹984₹15,424 cr5.5
Balmer Lawrie & Company Limited₹162₹2,778 cr9.7
TTK Healthcare Limitedthis company₹1,049₹1,482 cr17.4
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
0.95%
trailing 12 months
Dividend / share (TTM)
₹10
Last dividend
₹10
ex 17 Jul 2026
ActionDetailEx-date
Dividend₹10 / share17 Jul 2026
Dividend₹10 / share18 Jul 2025
Dividend₹10 / share16 Jul 2024
Dividend₹10 / share18 Jul 2023
Dividend₹10 / share26 Jul 2022
Dividend₹6 / share12 Aug 2021
Who owns it · 2026-06-30
No pledge
Promoter
74.6%
FII / Foreign
1.9%
DII / Domestic
2.2%
Retail / others
21.4%
Smart-money activity
Insider trades
BoughtThiruvallur Thatai Lakshman · Promoter Group2.53 L26 Dec 25
SoldLate Thiruvallur Thattai Venkatesh · Promoter Group14,00026 Dec 25
SoldLate Thiruvallur Thattai Jagannathan · Promoters7.59 L26 Dec 25
Bulk / block deals
SoldUNO METALS LTD · NSE76,500 @ ₹1,124.2417 Mar 25
BoughtUNO METALS LTD · NSE97,513 @ ₹1,541.5931 Jul 24
SoldCLUBMILLIONAIRE FINANCIAL SERVICES PRIVATE LIMITED · NSE87,335 @ ₹1,541.1331 Jul 24
Stake changes
BoughtMukund Thiruvallur Thattai · promoter→ 1.79% · 2.53 L26 Dec 25
BoughtMukund Thiruvallur Thattai · promoter→ 1.89% · 2.53 L26 Dec 25
BoughtSarayu Thiruvallur Thattai · promoter→ 1.89% · 2.67 L26 Dec 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Postal ballot · 24 Jan 2026
See the official result
1
Appointment of Mr V Sundaresan [DIN: 11435475] as an Independent Director of the Company, for a term of 5 years, with effect from December 22, 2025.
Backed by 100% of shareholders other than promotersneeded 75%
9.04 L votes for, 81 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 12 named members
owning 74.5% between them · as of 2026-06-30
T T Krishnamachari & Co. represented by its Partners -Mr T.T. Jagannathan and Mr T.T. Raghunnathan67.46%
MUKUND THIRUVALLUR THATTAI1.89%
SARAYU THIRUVALLUR THATTAI (Duly represented by Ms. Maitri Gopalakrishna, her Mother and Natural Guardian)1.89%
TIRUVALLUR THATAI LAKSHMAN1.89%
SHANTHI RANGANATHAN0.41%
BHANU RAGHUNATHAN0.40%
T T RAGHUNATHAN0.27%
LATHA JAGANNATHAN0.21%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.